Volumetric changes in hypothalamic subunits in patients with relapsing remitting multiple sclerosis

被引：0
作者：
Barış Genç
Sedat Şen
Kerim Aslan
Lütfi İncesu
机构：
[1] Samsun Education and Research Hospital,Department of Radiology
[2] Ondokuz Mayıs University School of Medicine,Department of Neurology
[3] Ondokuz Mayıs University School of Medicine,Department of Radiology
来源：
Neuroradiology | 2023年 / 65卷
关键词：
Relapsing remitting multiple sclerosis; Hypothalamus; Freesurfer; Brain atrophy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：899 / 905
页数：6
相关论文
共 50 条
  • [41] Effectiveness and safety of switching from fingolimod and natalizumab to rituximab in patients with relapsing remitting multiple sclerosis
    Fakih, Ali Ussama
    Sahraian, Mohammad Ali
    Paybast, Sepideh
    Moghadasi, Abdorreza Naser
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 71
  • [42] Investigation of oxidative stress in relapse and remission periods of patients with relapsing-Remitting multiple sclerosis
    Oncel, Samet
    Ozturk, Musa
    Gozubatik-Celik, Rabia Gokcen
    Soysal, Aysun
    Baybas, Sevim
    NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY, 2021, 38 (01): : 67 - 72
  • [43] Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
    Vazquez Gomez, Lazaro Aurelio
    Hidalgo Mesa, Carlos
    Broche Perez, Yunier
    Valdes Morales, Yanet
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2022, 20 (05): : 825 - 833
  • [44] Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients
    De Stefano, Nicola
    Tomic, Davorka
    Radue, Ernst-Wilhelm
    Sprenger, Till
    Meier, Daniela Piani
    Haring, Dieter
    Sormani, Maria Pia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 7 : 98 - 101
  • [45] Effectiveness of comprehensive neurorehabilitation treatment on the cognitive function of patients with relapsing-remitting multiple sclerosis
    Gomez, Lazaro Aurelio Vazquez
    Mesa, Carlos Hidalgo
    Perez, Yunier Broche
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2022, 20 (03): : 469 - 477
  • [46] Folate receptor alpha autoantibodies in the serum of patients with relapsing-remitting multiple sclerosis (RRMS)
    Mashayekhi, Farhad
    Hadipour, Elham
    Shabani, Somayeh
    Salehi, Zivar
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 237
  • [47] Optic coherence tomography findings in relapsing-remitting multiple sclerosis patients of the northwest of Iran
    Talebi, Mahnaz
    Nikanfar, Masoud
    Sorkhabi, Rana
    Sharifipour, Ehsan
    Bahrebar, Mansour
    Kiavar, Ali
    Andalib, Sasan
    Khanli, Hadi Mohammad
    IRANIAN JOURNAL OF NEUROLOGY, 2013, 12 (03) : 81 - 86
  • [48] Evaluation of serum human epididymis protein 4 in patients with relapsing-remitting multiple sclerosis
    Adamczyk, Bozena
    Partyka, Robert
    Adamczyk-Sowa, Monika
    Wierzbicki, Krzysztof
    Sowa, Pawel
    Kokocinska, Danuta
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (08): : 943 - 948
  • [49] Alemtuzumab induces severe orbitopathy in relapsing-remitting multiple sclerosis
    Gomez, Pablo Rodriguez de Vera
    Muros, Mariola Mendez
    Cuadro, Alberto Torres
    de Miera, Francisco Javier Toyos Saenz
    Ruiz, Rocio Lopez
    Vazquez, Raquel Guerrero
    Gonzalez, Juan Jesus Garcia
    Hermosilla, Antonio Manuel Garrido
    Hernandez, Tomas Martin
    JOURNAL OF NEUROLOGY, 2024, 271 (01) : 486 - 496
  • [50] Beta-interferons in the therapy of relapsing-remitting multiple sclerosis
    Klimová, E
    Szilasiová, J
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2003, 66 (05) : 343 - +
12345